Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study of Botulinum Neurotoxin Type A In Subjects With Crow's Feet (Lateral Canthal Lines)

NCT01951742 is registered in ClinicalTrials.gov with Anterios Inc. as lead sponsor.

NCT NCT01951742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study of Botulinum Neurotoxin Type A In Subjects With Crow's Feet (Lateral Canthal Lines)
Lead sponsor
Anterios Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
January 31, 2014
Enrollment
145 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

crow's feet, lateral canthal lines